i-Base home
Search Menu
  • Home
  • HTB
  • Conference reports
  • 6th International Congress on Drug Therapy in HIV Infection, 17-21 November 2002, Glasgow, UK

HTB

6th International Congress on Drug Therapy in HIV Infection, 17-21 November 2002, Glasgow, UK

1 February 2003. Related: Conference reports, Conference index, HIV 6th Glasgow 2002.

Some presentations from this meeting are online at the congference website:
http://www.hiv6.com/

Abstracts from the meeting are archived at:
http://www.aegis.org/

The following articles are included in coverage of this conference.

  • Combination of three generic drugs in one pill meets bioequivalence criteria when compared with the branded drugs: Triomune vs d4T/3TC/NVP
  • An overview of the conference
  • Pharmacokinetic evaluation of tenofovir and enteric-coated ddI
  • The advantages of fosamprenavir; comparing saquinavir/r to lopinavir/r; reducing viral load to <3 copies; AZT-d4T cross resistance; and rising HCV rates
  • Promising data regarding DermaVir for therapeutic vaccine
  • Enfuvirtide (T-20): predicting success and modelling survival benefits
  • Virologic failure among treatment-naive patients taking tenofovir DF or stavudine in combination with lamivudine and efavirenz
  • Comparison of the efficacy and safety of tenofovir vs. d4T when used in combination with 3TC and efavirenz in ARV-naive patients
  • Safety profile of tenofovir in treatment-experienced patients

Links to other websites are current at date of posting but not maintained.

  • HTB RSS
  • Volume 4 Number 1 January/February 2003
  • Volume 4 Number 2 March 2003 PDF

Early access

  • HIV guidelines recommend a statin for all people older than 40: new BHIVA document 21 November 2023
  • Dolutegravir monotherapy still not recommended: 4-year follow up in early-treated durably suppressed participants 12 November 2023
  • CHAI 2023 market report: decline in HIV funding threatens 20 years of progress 2 November 2023
  • Mpox vaccines still available and recommended in the UK and US 2 November 2023
  • All early access reports

Current issues

  • November 2023
  • October 2023
  • September 2023
  • Back issues

Special report

  • Uganda report: Increase in LGBTQI+ assaults and human rights violations need urgent activist responses 1 October 2023

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook